Paquet lab addresses iPSC limitation: new line with endogenous P301L/S320F 4R tau develops age-related tauopathy phenotypes stem cells typically fail to model. Platform shows pathological tau aggregation for more precise tauopathy research & drug screening
www.science.org/doi/10.1126/...
www.science.org
A human iPSC–derived tauopathy model endogenously recapitulates late-stage pathology and enables translational applications.